Medical therapy for MDR-TB is based on the combination at least 4 drugs, one drug from each of the drug groups for TB.  The duration of the treatment should be at least 18 months, depending on the culture results and clinical improvement.
Multi-drug-resistant tuberculosis medical therapy
Drug-resistant tuberculosis medical therapy
Tuberculosis medical therapy
Anthrax medical therapy
Opportunistic infection medical therapy
Bacterial pneumonia medical therapy
Mycoplasma pneumonia medical therapy
Multi-drug-resistant tuberculosis future or investigational therapies